Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,060Revenue (TTM) $M257Net Margin (%)-22.2Altman Z-Score1.6
Enterprise Value $M1,299EPS (TTM) $-1.3Operating Margin %-17.6Piotroski F-Score5
P/E(ttm)--Beneish M-Score-2.7Pre-tax Margin (%)-21.9Higher ROA y-yY
Price/Book11.710-y EBITDA Growth Rate %--Quick Ratio1.9Cash flow > EarningsY
Price/Sales4.15-y EBITDA Growth Rate %--Current Ratio2.3Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-12.7Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-49.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M43.0ROIC % (ttm)-13.6Gross Margin Increase y-yY

Gurus Latest Trades with SPNC

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SPNCRon Baron 2016-03-31 Reduce$11.42 - $15.94
($13.83)
$ 24.7679%Reduce -1.23%1,772,488
SPNCRon Baron 2015-12-31 Reduce-0.02%$10.78 - $15.77
($13.26)
$ 24.7687%Reduce -15.37%1,794,488
SPNCRon Baron 2015-09-30 Reduce-0.02%$11.55 - $25.67
($17.91)
$ 24.7638%Reduce -9.40%2,120,500
SPNCRon Baron 2015-06-30 Add0.13%$23.01 - $35.13
($28.04)
$ 24.76-12%Add 171.34%2,340,509
SPNCRon Baron 2015-03-31 Add0.08%$31.77 - $36.44
($34.01)
$ 24.76-27%Add 219.14%862,579
SPNCRon Baron 2014-09-30 Add0.03%$22.76 - $29.33
($27)
$ 24.76-8%Add 412.11%309,727
SPNCRon Baron 2014-06-30 Add$20.78 - $29.79
($23.2)
$ 24.767%Add 63.55%60,480
SPNCRon Baron 2014-03-31 Add$24.13 - $31.56
($27.26)
$ 24.76-9%Add 243.04%36,980
SPNCRon Baron 2013-12-31 Buy $17.2 - $25.43
($21.43)
$ 24.7616%New holding10,780
SPNCGeorge Soros 2011-09-30 Sold Out -0.0012%$5.6 - $7.62
($6.51)
$ 24.76280%Sold Out0
SPNCGeorge Soros 2011-06-30 Buy $4.68 - $6.21
($5.59)
$ 24.76343%New holding13,300
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SPNC is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SPNC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
RUGGIO JOSEPH MDirector 2016-08-11Sell5,000$25-0.92view
Drake Scott WilliamPresident, CEO 2015-11-06Buy38,000$13.2487.08view
JOHNSON B KRISTINEDirector 2015-11-05Buy2,000$1390.54view
FLETCHER R JOHNDirector 2015-10-28Buy8,240$12.04105.73view
FLETCHER R JOHNDirector 2015-10-26Buy8,000$12.4199.6view
PELAK DANIEL ADirector 2015-10-26Buy8,000$12.4598.96view
JENNINGS WILLIAM CDirector 2015-08-11Buy10,000$15.9755.1view
Bridges Kimberly McIntoshSr VP, Sales & Mktg, VI 2015-07-29Buy3,000$16.847.44view
PELAK DANIEL ADirector 2015-07-28Buy16,000$15.5759.09view
CHILDS GUY ACFO 2015-07-28Buy5,000$15.6758.07view

Press Releases about SPNC :

Quarterly/Annual Reports about SPNC:

News about SPNC:

Articles On GuruFocus.com
Steven Cohen's Point72 Raises Stake in Spectranetics Oct 22 2015 
Baron Funds Comments on The Spectranetics Corp. Aug 19 2015 
Baron Funds Comments on Spectranetics Corporation Feb 26 2014 
Spectranetics Corp. Reports Operating Results (10-Q) Nov 08 2010 
Spectranetics Corp. Reports Operating Results (10-Q) Nov 06 2009 
Spectranetics Corp. Reports Operating Results (10-Q) Aug 10 2009 
Spectranetics Corp. Reports Operating Results (10-Q) May 11 2009 
Weekly CEO Buys Highlight: Spectranetics Corp., Noven Pharmaceuticals Inc., Dolan Media Company, Mod Sep 09 2008 

More From Other Websites
ETF’s with exposure to The Spectranetics Corp. : August 11, 2016 Aug 11 2016
SPECTRANETICS CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Aug 11 2016
First Randomized Trial of the Stellarex™ Drug-coated Balloon Presented at the Amputation... Aug 10 2016
SPECTRANETICS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Aug 10 2016
Spectranetics Receives CE Mark for AngioSculptX™ Aug 10 2016
The Spectranetics Corp. :SPNC-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016 Aug 09 2016
Spectranetics downgraded by Needham Aug 09 2016
SPECTRANETICS CORP Financials Aug 04 2016
SPECTRANETICS CORP Files SEC form 10-Q, Quarterly Report Jul 29 2016
Edited Transcript of SPNC earnings conference call or presentation 28-Jul-16 8:30pm GMT Jul 29 2016
Spectranetics reports 2Q loss Jul 28 2016
Spectranetics reports 2Q loss Jul 28 2016
Spectranetics Corp Earnings Call scheduled for 4:30 pm ET today Jul 28 2016
SPECTRANETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 28 2016
Spectranetics Reports Second Quarter 2016 Revenue of $67.7 million Jul 28 2016
Q2 2016 Spectranetics Corp Earnings Release - After Market Close Jul 28 2016
QT Vascular Announces Federal Circuit Reversal of Adverse AngioScore / Spectranetics Judgment Jul 25 2016
Federal Circuit Court's Mixed Ruling In Patent Appeal Case Jul 21 2016
SPECTRANETICS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 21 2016
Federal Circuit Court Rules in Appeal Jul 21 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)